Clinical trials
Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
| Unknown status | 4 |
| Completed | 2 |
| Not yet recruiting | 2 |
| Suspended | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 4 |
| Beijing GoBroad Hospital | 2 |
| First Affiliated Hospital Xi'an Jiaotong University | 2 |
| Peking University People's Hospital | 2 |
| The Children's Hospital of Zhejiang University School of Medicine | 2 |
| Anhui Provincial Hospital | 1 |
| Bioray Laboratories | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| Hebei Senlang Biotechnology Inc., Ltd. | 1 |
| Philips (China) Investment CO., LTD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 22 |
| Burkitt Lymphoma | 3 |
| Multiple Myeloma | 3 |
| Lymphoma, Non-Hodgkin | 2 |
| Recurrence | 2 |
| Constipation | 1 |
| Disease | 1 |
| Graft vs Host Disease | 1 |
| Leukemia | 1 |
| Lymphoma | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.